209 related articles for article (PubMed ID: 14500761)
1. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
2. The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells.
Tirard M; Jasbinsek J; Almeida OF; Michaelidis TM
J Mol Endocrinol; 2004 Jun; 32(3):825-41. PubMed ID: 15171715
[TBL] [Abstract][Full Text] [Related]
3. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.
Tan J; Hall SH; Hamil KG; Grossman G; Petrusz P; Liao J; Shuai K; French FS
Mol Endocrinol; 2000 Jan; 14(1):14-26. PubMed ID: 10628744
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
Zennaro MC; Le Menuet D; Lombès M
Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
[TBL] [Abstract][Full Text] [Related]
6. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
7. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
Nishida T; Yasuda H
J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human mineralocorticoid receptor function by protein kinase A.
Massaad C; Houard N; Lombès M; Barouki R
Mol Endocrinol; 1999 Jan; 13(1):57-65. PubMed ID: 9892012
[TBL] [Abstract][Full Text] [Related]
9. NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers.
Okubo S; Hara F; Tsuchida Y; Shimotakahara S; Suzuki S; Hatanaka H; Yokoyama S; Tanaka H; Yasuda H; Shindo H
J Biol Chem; 2004 Jul; 279(30):31455-61. PubMed ID: 15133049
[TBL] [Abstract][Full Text] [Related]
10. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
12. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
13. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
16. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
17. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
[TBL] [Abstract][Full Text] [Related]
18. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
19. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
20. Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription.
Kurihara I; Shibata H; Kobayashi S; Suda N; Ikeda Y; Yokota K; Murai A; Saito I; Rainey WE; Saruta T
J Biol Chem; 2005 Feb; 280(8):6721-30. PubMed ID: 15611122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
